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Does a young woman living with a
smoker or taking a job working in a
smoky bar have a greater chance of devel-
oping breast cancer? Some scientists
believe that such situations can indeed
raise a woman’s risk of developing breast
cancer before the age of 50. Because epi-
demiological and toxicological studies
show that women’s breast tissue may be
especially sensitive to exposure to carcino-
gens prior to first pregnancy, these
researchers contend that public education
should be directed at alerting adolescents
and young women to the potential risk.
However, not everyone in the internation-
al public health community agrees that the
evidence to date supports a link between
passive smoking and breast cancer, and
some say that women are being alarmed
unnecessarily. This disagreement has
sparked debate that is sometimes heated. 
The stakes are high because breast can-
cer is the most common cancer in women
in industrialized countries, according to
the WHO. It is the leading cancer killer
of nonsmoking women, and second only
to lung cancer deaths among women who
smoke. 
Among the researchers interviewed for
this article who disagree that there is
enough evidence to link secondhand
smoke (SHS) with breast cancer, the
majority call the evidence to date “sugges-
tive but not sufficient,” as the Surgeon
General’s 2006 report, The Health Conse-
quences of Involuntary Exposure to Tobacco
Smoke, put it. That characterization is
based largely on the fact that the research
considered when the Surgeon General’s
report was being amassed did not clearly
link even active smoking to breast cancer.
Researchers in this camp do, however,
stress that ongoing campaigns to prohibit
smoking in public will protect the whole
of society against the wide variety of ills
proven to be caused by SHS. These
include lung cancer, cardiovascular dis-
ease, and sudden infant death syndrome,
among others.
A smaller group contends that the ques-
tion of whether or not SHS causes breast
cancer is a political issue with the potential
to compromise the scientific process. “A
premature decision about causality could
jeopardize the credibility of the entire
review process and all of the other, estab-
lished effects of secondhand smoke,” says
Michael Thun, national vice president of
epidemiology and surveillance research for
the American Cancer Society. Adds Valerie
Beral, director of the University of Oxford
Cancer Research UK Epidemiology Unit,
“To prematurely come to conclusions
about the causation when there is a big
division in the scientific community . . . is
bad science.” 
Thun debated the subject in a series of
public forums held in conjunction with
scientific meetings. Taking the opposing
view was Kenneth C. Johnson, a research
scientist with the Public Health Agency of
Canada, who was one of the first scientists
to discern a potential link. During the
debates, Johnson pointed out there are
about the same number of studies linking
breast cancer to passive smoking as there
were linking lung cancer to SHS in 1986,
when the Surgeon General concluded thatT
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passive smoking caused lung cancer.
Johnson also says that more of the breast
cancer studies are statistically significant,
and that the estimated risk for breast cancer
is higher. 
The Importance of Carcinogens in
Tobacco Smoke
The suspicion that exposure to SHS could
cause breast cancer dates back more than
two decades. Among the more than 50 car-
cinogens in tobacco smoke are approxi-
mately 20 substances listed as mammary
carcinogens by the International Agency
for Research on Cancer. These include
compounds such as dibenzo[a,1]pyrene,
which the research literature identifies as
an extremely potent carcinogen in mam-
mary tissue. 
The chemicals in tobacco smoke are a
mixed bag of directly genotoxic DNA-
damaging compounds (“initiators”), com-
pounds that enhance the action of these
initiators (“promoters”), and compounds
that do both, says Andrew Salmon, a toxi-
cologist at the California EPA’s Office of
Environmental Health Hazard Assessment
(Cal/EPA OEHHA). Some of these sub-
stances are more abundant in sidestream
smoke, which comes off the tip of the ciga-
rette, than the smoke inhaled by smokers
themselves. This sidestream smoke is the
major source of SHS.
Numerous studies have shown that tox-
icants from cigarette smoke reach rodent
mammary tissue and can form the DNA
adducts believed to represent the first step
of carcinogenesis. If not repaired or if
repaired incorrectly, these modifications
may eventually lead to mutations and ulti-
mately cancer. Irma Russo, a member of the
Fox Chase Cancer Center’s Medical Science
Division, says, “We know that [tobacco
smoke] is carcinogenic to the human breast
[because we have] utilized some of the car-
cinogens, such as benzo[a]pyrene, that are
present in tobacco smoke and induced
tumor formation in breast epithelial cells.”
What is less clear, she says, is when and how
this exposure causes cancer in women.
Jonathan Li, a professor in the Univ-
ersity of Kansas Medical Center Depart-
ment of Pharmacology, Toxicology, and
Experimental Therapeutics, contends that,
while it is true that some tobacco smoke
components are strong carcinogens in
rodent mammary tissue, the resulting
tumors do not reflect the histopathology or
molecular alterations seen in the vast
majority of human pre-malignancies or in
primary tumors except for their estrogen
dependency. “A case in point is that car-
cinogen-induced mammary tumors in
rodents are diploid, and human ductal
breast cancers are seventy to ninety percent
aneuploid,” says Li. “Only breast tumors
induced in rodents by estrogens are highly
aneuploid. This would suggest why there is
only a modest link between tobacco smoke
and human breast cancer risk.” 
Salmon and colleagues at the Cal/EPA
OEHHA dispute the validity of Li’s obser-
vations. Salmon points to the differences
not only between rodents and humans, but
between different rodent species. “For
instance,” he explains, “most mammary
cancers in mice are hormone-independent
at the time of detection, whereas nearly all
rat mammary tumors are hormone-
dependent initially. Human mammary
tumors are intermediate in this regard,
although the balance varies with age at
diagnosis. However . . . both rats and mice
are susceptible to mammary carcinogenesis
by tobacco smoke constituents.” Salmon
adds that karyotypic changes including
aneuploidy are commonly seen at the later
stages of tumor progression, but are not
necessarily related to the initial cause of the
tumor, being instead often dependent on
host-related factors. 
The data from epidemiological studies
are even murkier. Taken as a whole, the 26
studies on the topic to date appear inconclu-
sive, points out Alfredo Morabia, a professor
of epidemiology at the City University of
New York and lead author of a study in
the 1 May 1996 issue of the American
Journal of Epidemiology that did show a link.
“There are large prospective studies
that found no association, but some
case–control studies find a strong
association and others a weak associa-
tion,” he says. “Some studies indicate
that the issue is with younger women,
others with older women.” 
Others put it more bluntly. “If
smoking was a major cause of breast
cancer, we would have found it by
now,” says Dale Sandler, chief of the
NIEHS Epidemiology Branch, the
researcher who published an article
linking SHS exposure with several
kinds of cancers in the January 1985
American Journal of Epidemiology. Li
adds that one would anticipate that if
carcinogen–DNA adducts were an
important end point in human breast
cancer, this would eventually translate
into mutations in human breast cells.
“This is . . . not the case in sporadic
ductal breast cancer, which comprises
greater than ninety percent of all
breast cancer cases,” he says. 
The researchers who are con-
vinced that the data support a link
between SHS and breast cancer
counter that they do not claim that
such exposure is the major cause of breast
cancer, but simply one cause that many
women can easily avoid. Mark Miller, a
public health medical officer at the
OEHHA, and Johnson were among the
authors of Proposed Identification of Environ-
mental Tobacco Smoke as a Toxic Air Con-
taminant, the Cal/EPA’s first publication to
claim a causative link between exposure to
SHS and breast cancer. The 528-page
report was published in 2005 as part of the
evidence mustered by the agency in its ulti-
mately successful bid to become the first
state to identify SHS as an air pollutant
that could be regulated by the state. The
peer-reviewed report devoted 56 pages to
the toxicological and epidemiological evi-
dence for a link between breast cancer and
passive smoking, including a meta-analysis
of the 19 studies available at the time. The
WHO is in the process of republishing the
report in other languages for worldwide
dissemination. 
Miller, Johnson, and colleagues also
presented their case in a review article pub-
lished in the February 2007 issue of
Preventive Medicine with the goal of provid-
ing additional information about how they
made their determination for the medical
and public health communities. The new
paper reiterates that women regularly
exposed to SHS increase their relative risk
of developing breast cancer by age 50
between 68% and 120%. These estimates
were first calculated and published in a
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meta-analysis by Johnson that appeared in
the 20 November 2005 issue of the Inter-
national Journal of Cancer. 
Exposure Assessment and Age
There are two important reasons why the
breast cancer risk from passive smoking can
be difficult to tease out from earlier studies:
exposure assessment and age. Melanie
Marty, chief of the Air Toxicology and Epi-
demiology Branch of the OEHHA and a
coauthor of the Preventive Medicine paper,
explains, “Exposure assessment is always an
issue in epidemiology studies, unless they
are lucky and have lots of exposure data. In
the case of secondhand tobacco smoke,
many of these studies didn’t do a very thor-
ough job of determining how long people
were exposed, when in their lifetimes they
were exposed, how much they were
exposed.” Further, she continues, if expo-
sure to SHS is not assessed carefully, “you
are going to mix up the group that you
think is unexposed with the group that you
think is exposed.” 
To address the issue of accurate expo-
sure reporting, the 2005 Cal/EPA report
identified a subgroup of studies that did a
better job of assessing exposure, which were
weighed more heavily in the final evalua-
tion. The report also broke out younger,
primarily premenopausal women—which
it defined as under the age of 50—as the
most vulnerable. This subgroup was first
highlighted by Johnson in 2000, and the
idea has been reaffirmed in recent findings.
For instance, although researchers from the
M.D. Anderson Cancer Center recently
reported a dramatic 7% overall drop in
breast cancer rates between 2002 and 2003,
the decline was mainly observed in women
aged 50 and older. The drop among
younger women was much lower—only
1% for women aged 40 to 49, for example.
These data were presented in December
2006 at the San Antonio Breast Cancer
Symposium. 
Only fourteen of the studies looking at
passive smoking and breast cancer allowed
analysis by menopausal status, according
to the 2005 Cal/EPA report. These
included ten case–control studies and four
prospective cohort studies that began fol-
lowing a large group of women before any
had the disease. Thirteen of these studies
reported elevated risk estimates for breast
cancer in premenopausal women, and the
risk was statistically significant in seven of
the studies. 
The preponderance of case–control
studies is a weakness of the case for linking
breast cancer with passive smoking, an issue
that Thun stressed in his debates with
Johnson last summer. All things being equal,
epidemiologists generally consider the find-
ings of cohort studies to be more persuasive
than those of case–control studies, because
exposure information is ascertained before
the development of disease and because both
cases and noncases arise from the same study
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A matter of age.
Much of the discrepancy
in findings related to
passive smoking and
breast cancer may relate
to differences between
younger and older
women. Premenopausal
women are believed to
be more vulnerable to
breast cancer. population. Beral points out that “every
textbook of epidemiology says that once
someone has a disease they might remem-
ber things differently.” 
In response, Johnson says he doubts
that recall bias explains premenopausal risk,
pointing out that one would expect to
observe similarly increased risk for pre- and
postmenopausal women, which has not
been seen. He says it is very difficult to col-
lect good information about passive smok-
ing in prospective study questionnaires. 
“In a cohort study, you [might] have
to interview a hundred thousand [people]
in order to get a thousand cases. In a
case–control study, you may have a thou-
sand cases and a thousand controls, so you
have to interview two thousand to find out
the demographic and exposure informa-
tion of interest,” he explains. “Because you
have to interview fifty times as many peo-
ple [in a cohort study], there’s a much
higher price [in terms of administering the
questionnaire] associated with every ques-
tion you ask about exposure—the depth
and quality of the exposure measures tend
to be less unless it is a real focus of the
cohort study.” 
Further, says Russo, a woman might
not know whether her grandparents, par-
ents, and other relatives living in the same
household smoked, and how much and for
how long, nor whether her mother smoked
during pregnancy.
Another issue that continues to plague
efforts to link passive smoking to breast
cancer is the fact that many researchers feel
that epidemiological studies have not con-
clusively linked even active smoking to the
disease. This, says Jonathan Samet, chair-
man of the Johns Hopkins Bloomberg
School of Public Health and the senior sci-
entific editor for the Surgeon General’s
2006 report, is one reason that report called
the breast cancer–passive smoke evidence
“suggestive but not sufficient.”
Stanton Glantz, a professor of medicine
at the University of California, San
Francisco, Medical School, claims this is
because many of the most recent reports on
active smoking weren’t considered when the
Surgeon General’s report was being pro-
duced. The Preventive Medicine paper says
that six large prospective studies have now
found a statistically significant elevated risk
for breast cancer among smokers for at least
some metrics of exposure.  
Peggy Reynolds, a cancer epidemiolo-
gist at the Northern California Cancer
Center, is the lead author of one of the
case–control studies that does support a
link between active smoking and breast
cancer, published in the 7 January 2004
Journal of the National Cancer Institute. She
and her colleagues have been following
116,544 California teachers since 1995,
and reported that the incidence of breast
cancer among the cohort’s current smokers
was higher than that for members who had
never smoked. She said that the risk dou-
bled for smokers with more than 31 pack-
years—the equivalent of smoking one pack
of cigarettes per day over the course of 31
years—compared with nonsmokers. 
Although Reynolds did not report find-
ing a link between passive smoking and
breast cancer in that paper, she stresses that
this could be because the questionnaire
used to capture the data included informa-
tion about whether women were exposed to
smoking only in their homes. In a follow-
up questionnaire, she and her colleagues
asked more detailed questions to include
other sources of passive exposure, particu-
larly the workplace, and those data are cur-
rently being analyzed. These additional
data are important because, although
household exposures represented the major
exposure source for women in this cohort
during earlier decades, “following 1970, the
workplace became women’s most impor-
tant source of exposure to secondhand
smoke,” she says. 
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In both their report and review article,
Johnson and the Cal/EPA researchers also
evaluated the biological plausibility of just
how exposure to SHS might cause breast can-
cer, and concluded that “the chain of evidence
indicates that a causal association is highly
plausible.” Glantz points out that this isn’t
always taken into consideration in epidemio-
logical studies, which he argues gives the
team’s conclusion all that much more weight. 
A Nonlinear Relationship
However, the chain of evidence regarding
biological plausibility doesn’t fit neatly with
the fact that active smoking does not cause a
significantly higher number of breast cancers
compared with passive smoking exposure.
“One reasonable biological explanation for
the similarity in risk would be that the
tobacco smoke exposure pathways might
become saturated at levels of exposure asso-
ciated with regular secondhand smoke expo-
sure, so that the higher exposure [from active
smoking] would not further elevate the
risk,” Johnson says. 
It also appears that active smoking may
partially mitigate effects of carcinogen expo-
sure on the breast in smokers by reducing
their estrogen levels. This fits with the M.D.
Anderson study, which credited the declin-
ing popularity of hormone replacement
therapy for the decreasing rates of breast can-
cer among older women. It might also
explain why passive smoking, which is
hypothesized to have less impact than active
smoking on estrogen levels, could be associ-
ated with breast cancer. The problem with
this, as Thun points out, is that no toxico-
logical data exist to show there is a nonlinear
relationship between the effects of low and
high doses of smoke exposure.
Another potential explanation is that
women may be especially susceptible dur-
ing a key “window of exposure” that
researchers have previously identified—
namely, between puberty and when a
woman bears her first child. Data from
Hiroshima and Nagasaki, as well as from
the treatment of young women with
Hodgkin disease, show that the breast is
not protected from potentially harmful
environmental agents until it becomes
fully differentiated in preparation for pro-
ducing milk. This does not occur until the
first full-term pregnancy. Pierre Band of
Health Canada’s Division of Epidemiology
and Cancer Prevention led a case–control
study that supports the “window of
exposure” hypothesis. Published in
the 5 October 2002 issue of The Lancet, it
showed that women who started smoking
within five years of menarche were around
70% more likely to develop breast
cancer than nonsmokers. 
Many researchers interviewed for
this article agreed that drinking alco-
holic beverages does promote breast
cancer, but not everyone felt that this
factor has been adequately separated
from tobacco exposure. “The breast
cancer–alcohol association . . . is quite
widely reported, but it is very hard to
quantify and separate from the effects
of concurrent active and passive
smoking,” Salmon points out.
“There’s also a complex multiway
interaction between alcohol intake,
smoking exposures, hormone levels,
obesity, and breast cancer,” he adds. 
The evidence for a breast can-
cer–alcohol link was presented in a
large meta-analysis by Beral and
colleagues that included over 50
studies and data from more than
150,000 women. That analysis,
published in the 18 November
2002  British Journal of Cancer,
found no link between active smok-
ing and breast cancer, but Reynolds
says her study showed otherwise;
the data showed that the link
between active smoking and breast
cancer held whether or not alcohol
consumption was considered. She
says, “We did a second analysis . . .
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A continuing revolution?
As the female workforce
grew at the end of the
twentieth century, the job
site became an important
source of SHS exposure for
many women. Today, how-
ever, health concerns and
protests (like this one, right,
at a January 2007 Atlantic
City council meeting) have
led to laws that protect
such workers. limited to nondrinkers, and we found the
same elevated risk association.” 
Johnson suggests that because passive
smoking was not considered in Beral’s meta-
analysis of alcohol risk, it is possible that it
could have confounded the alcohol associa-
tion results. He adds that the study simply
compared women who said they currently
smoked to women who reported smoking
previously and those who said they never
smoked, with no consideration of how much
the women had smoked over their lifetimes.
Salmon says that if there is in fact an
increase in breast cancer incidence directly
caused by alcohol—as opposed to an asso-
ciation related to co-exposures—then pro-
motional effects on cell growth might be
involved. “At least,” he says, “there is a con-
trast with tobacco smoke, where genotox-
ic carcinogens are clearly present and
involved along with other types of effects,
and carcinogen–DNA adducts have been
observed in the breast tissue of exposed
women.” 
However, Li notes there are numerous
studies that show that women metabolize
alcohol much more slowly than men, and
that serum concentrations of 17β-estradiol
are elevated after alcohol ingestion. “This,”
he says, “is likely the reason why alcohol
ingestion increases breast cancer risk.”
Although it had yet to be published
when this article was being written, a new
analysis by Beral and colleagues that linked
alcohol to breast cancer is already having an
effect on this debate. Thun said that after
being briefed on the new data, he decided to
hold off on moving forward with a work-
shop that the American Cancer Society
planned to fund to identify the outstanding
questions in the breast cancer–passive smok-
ing debate. Beral would not comment on the
data other than to say that the “findings are
essentially null.” She said the analysis includ-
ed 22 studies as well as new data and “sever-
al measures of exposure to secondhand
smoke.” An article in the 1 January 2007
Boston Globe said the study focused on
1.3 million women aged 50 to 64, a differ-
ent population than what the Cal/EPA sci-
entists say is at greatest risk. 
What Next?
While some members of the research com-
munity are perturbed by the disagreement
regarding the strength of the evidence con-
necting passive smoking and breast cancer,
Samet says he thinks it is to be expected.
“People should not be surprised if review
groups don’t exactly come into complete
alignment. Different groups bring expert
judgment to bear in somewhat parallel but
not definitely overlapping processes. I
don’t think that the way we approach evi-
dence review and synthesis is leading us
astray,” he says.
Samet says that he would like to see the
biological understanding advanced on ways
that SHS could cause breast cancer. “Of
course the simple story is that there are car-
cinogens in tobacco smoke, and they reach
breast tissue, which is true,” he says. “[What
makes the issue so complex is that] we
would expect that far greater doses of these
carcinogens would reach the breast tissue of
women who actively smoke. We have not
seen a clear signal showing that this is the
case. I would like to see the biological
framework laid out and better understood,
as well as watch the epidemiological evi-
dence grow.” Both the National Cancer
Institute (NCI) and the NIEHS are funding
research aimed at providing additional evi-
dence on the topic. [For more information
on this research, see “Centered on Breast
Cancer,” p. A132 this issue.]
The Cal/EPA researchers contend it is
likely that there are a number of subgroups
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20 Mammary Carcinogens in SHS
Acrylamide
Acrylonitrile
1,3-Butadiene
Isoprene
Nitromethane
Propylene Oxide
Dibenz[a,h]anthracene
Vinyl chloride
4-Aminobiphenyl
Urethane
Benzene
Nitrobenzene
Benzo[a]pyrene
ortho-Toluidine
Dibenzo[a,e]pyrene
Dibenzo[a,i]pyrene
Dibenzo[a,l]pyrene
N-Nitrosodiethylamine
N-Nitrosodi-n-butylamine
Source: Miller et al. Prev Med 44:93–106 (2007).Environmental Health Perspectives • VOLUME 115 | NUMBER 3 | March 2007 A 143
genetically susceptible to breast cancer who
could be especially sensitive to tobacco
smoke exposure depending upon the poly-
morphisms of several genes. This is plausible,
says Deborah Winn, acting associate director
of the NCI’s Epidemiology and Genetics
Research Program. “To actually look at
gene–environment interactions and then try
to look at breast cancer subgroups—you run
out of numbers very quickly,” she says. 
For that reason, researchers with the
NCI Cancer Genetic Markers of Suscep-
tibility initiative are doing genome-wide
scans on more than 500,000 single-
nucleotide polymorphisms and looking for
changes between breast cancer patients and
controls in a hypothesis-free approach.
“Eventually, you might find things that map
up to candidate genes that you already
thought—on the basis of function or their
role in estrogen metabolism—might be
involved,” Winn says. Other research is
focused on more detailed looks at promising
candidate genes, she says.
Says Russo, “The fact that carcinogen-
metabolizing enzymes such as CYP1A1 are
increased in both lung and breast cancers,
but that the death rate from lung cancer in
American women has increased six hundred
percent from 1930 to 1997, whereas breast
cancer has remained stationary during the
same period, might suggest that women car-
riers of susceptibility genes would be more
prone to develop both breast and lung can-
cer. Unfortunately, statistics on the incidence
of breast lesions in women diagnosed with
lung cancer are almost nonexistent.”
Sandler is currently in the process of
recruiting women for an NIEHS-funded
prospective study of sisters of women who
have or had breast cancer; this group is
twice as likely as other women to develop
breast cancer. She has already enrolled
30,000 such women who don’t have breast
cancer, and she aims to sign up 20,000
more. “The purpose is to look at environ-
mental and genetic risk factors for breast
cancer—certainly . . . we’ll be looking at
their life history of exposure to cigarette
smoke, their own and through their parents
and their spouses and their roommates and
their jobs,” she says. “The questionnaires
were designed to do a thorough job of look-
ing at it.”
Just what all this research will show is
unclear. The only certainty, Samet says, is
that “scientific evidence will continue to
accumulate on this topic.” 
Kellyn S. Betts
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Noisy environment.
Drinking adds another
dimension to the uncertain-
ty about the effects of SHS.
Breast cancer studies pub-
lished to date have been
unable to tease out the
effects of concurrent active
and passive smoking from
alcohol intake. 
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